(Reuters) - Last month's Supreme Court ruling that upheld President Barack Obama's 2010 healthcare law could save the U.S. government some $84 billion over 11 years, the non-partisan Co...
Click here to view
2012-07-25 |
Comment(0) | View(9)
(Reuters) - U.S. health regulators should change the prescription guidelines for opioid painkillers to prevent more people abusing the powerful and addictive medicines, urged a gro...
Click here to view
2012-07-25 |
Comment(0) | View(4)
(Reuters) - U.S. drug reviewers on Tuesday said Roche Holding AG's eye drug Lucentis appeared to help diabetic patients with a vision-robbing eye condition, but questioned whether...
Click here to view
2012-07-24 |
Comment(0) | View(5)
(Reuters) - Efforts to reduce risky sexual behavior among U.S. high school students have stalled in the past decade and urgent action is needed to stem HIV infection rates in young peopl...
Click here to view
2012-07-24 |
Comment(0) | View(3)
(Reuters) - Efforts to reduce risky sexual behavior among U.S. high school students have stalled in the past decade and urgent action is needed to stem HIV infection rates in young people, who ...
Click here to view
2012-07-24 |
Comment(0) | View(1)
(Reuters) - Efforts to reduce risky sexual behavior among U.S. high school students have stalled in the past decade and urgent action is needed to stem HIV infection rates in youn...
Click here to view
2012-07-24 |
Comment(0) | View(0)
(Reuters) - Philanthropist and AIDS prevention advocate Bill Gates said on Monday there had been significant advances in the fight against HIV/AIDS, but he was not ready to say the worl...
Click here to view
2012-07-24 |
Comment(0) | View(4)
(Reuters) - The number of rating downgrades for non-profit hospitals outpaced upgrades in the first quarter of 2012, Moody's Investors Service said on Monday, adding it rema...
Click here to view
2012-07-23 |
Comment(0) | View(3)
(Reuters) - Breast cancer cells can destroy a powerful immune response in the body and allow the disease to spread to the patient's bones, researchers in Australia ...
Click here to view
2012-07-23 |
Comment(0) | View(4)
(Reuters) - European regulators have recommended approval of the Western world's first gene therapy drug -- after rejecting it on three previous occasions -- in a significant adv...
Click here to view
2012-07-20 |
Comment(0) | View(20)
(Reuters) - U.S. drug regulators approved Onyx Pharmaceuticals Inc's Kyprolis for people with multiple myeloma who have failed to successfully treat their blood cancer with other ...
Click here to view
2012-07-20 |
Comment(0) | View(3)
(Reuters Health) - Some women with unexplained fatigue may get a bit more pep from iron supplements - even if they do not have full-blown anemia, a new clinical trial suggests.
T...
Click here to view
2012-07-20 |
Comment(0) | View(7)
(Reuters) - Express Scripts Holding Co and Walgreen Co said Thursday that they had struck a pharmacy network agreement that settles a long-running dispute, sending shares of both ...
Click here to view
2012-07-20 |
Comment(0) | View(2)
Credit: Reuters/Illustration by Art Lien/Handout
(Reuters) - U.S. Supreme Court Justice Antonin Scalia said there was no bad blood between himself and Chief Justice John Roberts,...
Click here to view
2012-07-19 |
Comment(0) | View(13)
* Quest sees 2012 rev growth of 1-2 pct vs prior view of 2-2.5 pct
* Quest maintains 2012 EPS view
* LabCorp narrows 2012 revenue view
(Reuters) - The top two labora...
Click here to view
2012-07-19 |
Comment(0) | View(13)
(Reuters) - The top two laboratory testing providers, Quest Diagnostics Inc and Laboratory Corp of America Holdings, lowered their revenue forecasts for the year as patients go in...
Click here to view
2012-07-19 |
Comment(0) | View(8)
(Reuters) - AstraZeneca is to conduct a new global clinical trial of key new heart drug Brilinta involving 11,500 patients with peripheral artery disease, Britain's second biggest drugm...
Click here to view
2012-07-18 |
Comment(0) | View(2)
(Reuters) - Four Alzheimer's patients treated with an immune system therapy have seen their disease stabilize for at least three years, raising hope that the drug from Baxter Internation...
Click here to view
2012-07-18 |
Comment(0) | View(3)
(Reuters) - GlaxoSmithKline Plc is to acquire its long-time partner Human Genome Sciences Inc for a sweetened offer of about $3 billion, ending on friendly terms a three-month hostile p...
Click here to view
2012-07-17 |
Comment(0) | View(6)
(Reuters) - Human Genome Sciences Inc has agreed to be acquired by GlaxoSmithKline Plc, subject to approval of some last-minute details, for about $14 a share in cash, two sources familiar wit...
Click here to view
2012-07-16 |
Comment(0) | View(2)
